Eric McCafferty

We have entered "Fourth Wave" of addiction crisis that has already taken 1 million lives since 2000 in US—a lethal convergence of Fentanyl, Methamphetamine, and Xylazine. Unlike previous waves, crisis is not defined solely by overdoses, but by explosion of chronic, high-acuity disability that needs to better tracked, understood, and managed with data, insight, and AI.

Narcan availability keeps us

- Promoted from Enterprise Prompt Writer to Expert LLM Agentic AI Reviewer within weeks of onboarding, taking on expanded QC audit, rubric calibration, and cross-pod review responsibilities across a large-scale LLM evaluation program
- Designed and authored expert-level enterprise prompt-and-rubric task pairs used to train and evaluate next-generation large language models, targeting induced model

Have the privilege and pleasure to serve, in an advisory and consultative capacity, various leading institutions across Healthcare (e.g., Big 3 distributors, managed care, pharmacies, hospitals, home health, substance abuse and recovery, medical product, etc.), Investment (e.g., hedge, PE, credit, family offices, sovereign wealth), and Non-Profits (e.g., Foundations, NGOs, Governments). Across o

Involved in areas related to Climate Change, Healthcare, and innovative Private Sector partnerships and operating models. Led design, strategic focus, and talent development plan for new division at Gates Foundation, accompanied by $1.4 billion startup investment.

•    $8B Walgreens ex-US Acquisition (Alliance Healthcare):  Co-led this multi-jurisdictional cross-border transaction spanning 11+ countries across pharmaceutical wholesaling, retail pharmacy, and pharma services
•    $1B Asembia Specialty Pharmacy GPO Acquisition:  Led commercial diligence, strategic rationale to the Executive Committee, and integration planning; expanded specialty distribution

Worked for various PE-backed operating companies (Patheon, Axia, AdaptHealth, PPD, Mallinckrodt) owned by different PEs (JLL, Carlyle, H&F, Audax, Silverlake, Blue Mountain) in various capacities (strategy, M&A, turnaround, operational leadership) to drive profitable growth and often prepare for sale or merger or IPO.

Executive leadership for portfolio companies backed by Carlyle, Silver Lake, Hellman & Friedman, and Audax.

Industry focus across various aspects of Healthcare ecosystem with Functional experience in strategy, diligence, mergers and acquisitions, and turnaround and transformation.

McKinsey offered immersion program across Corporate Finance, Managerial Accounting, etc,

completed in 3 years

One of 50 undergraduates globally to be awarded prestigious one-year research fellowship for full-time role, as had completed double-major at Haverford in 3 years already

Completed dual degree in Biochemistry and Social Theory with minor in Physical Chemistry. Completed all academic work in 3 years.

Completed dual degree in Biochemistry and Social Theory with minor in Physical Chemistry. Completed all academic work in 3 years.

Studied biochemistry and molecular biology.

Completed dual B.S. in Biochemistry in 3 years.